Sun, Yaoting

Combination of dihydromyricetin and ondansetron strengthens antiproliferative efficiency of adriamycin in K562/ADR through downregulation of SORCIN: A new strategy of inhibiting P-glycoprotein. [electronic resource] - Journal of cellular physiology 04 2019 - 3685-3696 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1097-4652

10.1002/jcp.27141 doi


ATP Binding Cassette Transporter, Subfamily B--genetics
Antineoplastic Combined Chemotherapy Protocols--pharmacology
Apoptosis--drug effects
Calcium-Binding Proteins--genetics
Cell Proliferation--drug effects
Down-Regulation
Doxorubicin--metabolism
Drug Resistance, Neoplasm
Extracellular Signal-Regulated MAP Kinases--metabolism
Flavonols--pharmacology
G2 Phase Cell Cycle Checkpoints
Gene Expression Regulation, Neoplastic
Humans
K562 Cells
Leukemia--drug therapy
Ondansetron--pharmacology
Proto-Oncogene Proteins c-akt--metabolism
Signal Transduction